Diabetes mellitus in Egypt: Glycaemic control and microvascular and neuropathic complications

Diabetic Medicine

Volumn 15, Issue 12, 1998, Pages 1045-1051

  Herman, W H ^a   Aubert, R E ^b   Engelgau, M M ^b   Thompson, T J ^b   Ali, M A ^d   Sous, E S ^d   Hegazy, M ^d   Badran, A ^d   Kenny, S J ^b   Gunter, E W ^c   Malarcher, A M ^b   Brechner, R J ^b   Wetterhall, S F ^b   DeStefano, F ^b   Smith, P J ^b   Habib, M ^d   Abd El Shakour, S ^d   Ibrahim, A S ^d   El Behairy, El Moneim ^d  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^d MINISTRY OF HEALTH   (Egypt)

Author keywords

Blindness; Diabetes mellitus; Diabetic nephropathy; Diabetic neuropathy; Diabetic retinopathy; Egypt; Epidemiology; Glycosylated haemoglobin; Middle East

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C;

ADULT; ARTICLE; BLINDNESS; CLINICAL FEATURE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; EGYPT; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROTEINURIA;

ADULT; ALBUMINURIA; BLOOD GLUCOSE; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; HEALTH SURVEYS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; RURAL POPULATION; URBAN POPULATION;

EID: 14444285473     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(1998120)15:12<1045::AID-DIA696>3.0.CO;2-L     Document Type: Article

References (30)

1. WHO/EM/dia/3/E/G Diabetes Prevention and control. A call for action. Alexandria, Egypt: World Health Organization Regional Office for the Eastern Mediterranean, 1993.
2. Alwan A. Noncommunicable diseases: a major challenge to public health in the region. Eastern Mediterranean Hlth J 1997; 3: 6-16.
3. Herman WH, Ali MA, Aubert RE, Engelgau MM, Kenny SJ, Gunter EW, et al. Diabetes mellitus in Egypt -risk factors and prevalence. Diabetic Med 1995; 12: 1126-1131.
4. Laffel LBM, Warram JH, Krolewski AS. Glycemic control does not predict progression from low to high microalbuminuria in insulin-dependent diabetes mellitus (IDDM) (Abstract). J Am Soc Nephrol 1994; 5: 379.
5. Siegel JE, Krolewski AS, Warram JH, Weinstein MC. Cost-effectiveness of screening and early treatment of nephropathy in patients with insulin-dependent diabetes mellitus. J Am Soc Nephrol 1992; 3:(suppl 1): S111-S119.
6. Almdal T, Nörgaard K, Feldt-Rasmussen B, Deckert T. The predictive value of microalbuminuria in IDDM. Diabetes Care 1994; 17: 120-125.
7. World Health Organization: Diabetes Mellitus. Report of a WHO Study Group. Technical Report Series No. 727. Geneva: WHO, 1985.
8. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995; 18: 258-268.
9. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 1993; 329: 977-986.
10. Cowie CC, Harris MI. Physical and metabolic characteristics of persons with diabetes. In: National Diabetes Data Group, eds., Diabetes in America, 2nd edn. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, NIH Publication No. 95-1468. 1995: 117-133.
11. Klein R, Klein BEK. Vision disorders in diabetes. In: National Diabetes Data Group, eds. Diabetes in America, 2nd edn. National Institutes of Health, National Institute of Diabetes and Digestive Kidney Diseases, NIH Publication No. 95-1468. 1995: 293-338.
12. Houston A. Retinopathy in the Poole area: An epidemiological inquiry. In: Eschwege E, ed. Advances in Diabetes Epidemiology. Amsterdam: Elsevier, 1982.
13. Constable IJ, Knuiman MW, Welborn TA, Cooper RL, Stanton KM, McCann VJ, Grose GC. Assessing the risk of diabetic retinopathy. Ami Ophthalmol 1984; 97: 53-61.
14. Ross SA. Huchcroft SA. Hyperlipidemia and vascular risk factors among diabetics in southern Alberta. Clin Invest Med 1989; 12: B25.
15. Nielsen NV. Diabetic retinopathy. I. The course of retinopathy in insulin-treated diabetics. A one-year epidemiologic cohort study of diabetes mellitus. The Island of Plaster, Denmark. Acta Ophthalmol 1984; 62: 256-265.
16. Nielsen NV. Diabetic retinopathy. II. The course of retinopathy in diabetics treated with oral hypoglycemic agents and diet regime alone. A one-year epidemiologic cohort study of diabetes mellitus. The Island of Plaster, Denmark. Acta Ophthalmol 1984; 62: 266-273.
17. Haffner SM, Fond D, Stern MP, Pugh JA, Hazuda HP, Patterson JK, et al. Diabetic retinopathy in Mexican Americans and non-Hispanic whites. Diabetes 1988; 37: 878-884.
18. Thompson TJ, Engelgau MM, Hegazy M, Ali MA, Sous ES, Badran A, Herman WH. The onset of NIDDM and its relationship to clinical diagnosis in Egyptian adults. Diabetic Med 1996; 13: 337-340.
19. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care 1992; 15: 815-819.
20. Busted N, Olsen T, Schmitz O. Clinical observation on the corneal thickness and corneal endothelium in diabetes mellitus. Br J Ophthalmol 1981; 65: 687-690.
21. Schultz RO, VanHorn DL, Peters MA, et al. Diabetic keratopathy. Trans Am Ophthalmol Soc 1981; 79: 180-199.
22. Alzaid AA, Sobki S, De Silva V. Prevalence of microalbuminuria in Saudi Arabians with non-insulin-dependent diabetes mellitus: a clinic-based study. Diabetes Res Clin Pract 1994; 26: 115-120.
23. American Diabetes Association. Consensus development conference on the diagnosis and management of nephropathy in patients with diabetes mellitus. Diabetes Care 1994; 17: 1357-1361.
24. Klein R, Klein BEK, Moss SE. Prevalence of microalbuminuria in older-onset diabetes. Diabetes Care 1993; 16: 1325-1330.
25. Walters DP, Gatling W, Mullee MA, Hill RD. The prevalence of diabetic distal sensory neuropathy in an English Community. Diabetic Med 1992; 9: 349-353.
26. Kumar S, Ashe HA, Parnell LN, Fernando DJS, Tsigos C, Young RJ, et al. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study. Diabetic Med 1994; 11: 480-484.
27. Dyck PJ, Kratz KM, Lehman KA, Karnes JL, Melton III JL, O'Brien PC, et al. The Rochester Diabetic Neuropathy Study. Neurology 1991; 41: 799-807.
28. Franklin GM, Kahn LB, Baxter J, Marshall JA, Hamman RF. Sensory neuropathy in non-insulin-dependent diabetes mellitus: The San Luis Valley Diabetes Study. Am J Epidemiol 1990; 131: 633-643.
29. Herman WH, Greene DA. Microvascular complications of diabetes. In: Haire-Joshu, ed. Management of Diabetes Mellitus, 2nd edn. St Louis, MO: Mosby-Year Book, 1996: 234-280.
30. Walters DP, Catling W, Mullee MA, Hill RD. The distribution and severity of diabetic foot disease: a community study with comparison to a non-diabetic group. Diabetic Med 1992; 9: 354-358.